References
- Cheung WI, Tse ML, Ngan T, et al. (2009). Liver injury associated with the use of Fructus psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine. Clin Toxicol 47:683–5
- Fleming CD, Edwards CC, Kirby SD, et al. (2007). Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabun. Biochemistry 46:5063–71
- Ko KWS, Erickson B, Lehner R. (2009). Es-x/Ces1 prevents triacylglycerol accumulation in McArdle-RH7777 hepatocytes. Biochim Biophys Acta 1791:1133–43
- Laizure SC, Parker RB, Herring VL, Hu ZY. (2014). Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis. Drug Metab Dispos 42:201–6
- Lau KM, Wong JH, Wu YO, et al. (2014). Anti-dermatophytic activity of bakuchiol: in vitro mechanistic studies and in vivo tinea pedis-inhibiting activity in a guinea pig model. Phytomedicine 21:942–5
- Li YG, Hou J, Li SY, et al. (2015). Fructus Psoraleae contains natural compounds with potent inhibitory effects towards human carboxylesterase 2. Fitoterapia 101:99–106
- Li WD, Yan CP, Wu Y, et al. (2014). Osteoblasts proliferation and differentiation stimulating activities of the main components of Fructus Psoraleae corylifoliae. Phytomedicine 21:400–5
- Liu ZM, Feng L, Ge GB, et al. (2014). A highly selective ratiometric fluorescent probe for in vitro monitoring and cellular imaging of human carboxylesterase 1. Biosens Bioelectron 57:30–5
- Muller I, Besta F, Schulz C, et al. (2003). Effects of statins on platelet inhibition by a high loading dose of clopidogrel. Circulation 108:2195–7
- Sanghani SP, Sanghani PC, Schiel MA, Bosron WF. (2009). Human carboxylesterases: an update on CES1, CES2, and CES3. Protein Pept Lett 16:1207–14
- Satoh T, Hosokawa M. (2006). Structure, function and regulation of carboxylesterases. Chem Biol Interact 162:195–211
- Tarkiainen EK, Holmberg MT, Tornio A, et al. (2015). Carboxylesterase 1 c.428G > A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans. Clin Pharmacol Ther 97:650–8
- Wang X, He Y, Guo B, et al. (2015). In vivo screening for anti-osteoporotic fraction from extract of herbal formula Xianlinggubao in ovariectomized mice. PLoS One 10:e0118184
- Xu J, Li Y, Chen WD, et al. (2014). Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis. Hepatology 59:1761–71
- Zhang J, Burnell JC, Dumaual N, Bosron WF. (1999). Binding and hydrolysis of meperidine by human liver carboxylesterase hCE-1. J Pharmacol Exp Ther 290:314–8
- Zhu HJ, Markowitz JS. (2013). Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activation. Eur J Clin Pharmacol 69:733–4